106 related articles for article (PubMed ID: 7965775)
61. Magnetic resonance imaging of acute myocardial ischemia using a manganese chelate, Mn-DPDP.
Pomeroy OH; Wendland M; Wagner S; Derugin N; Holt WW; Rocklage SM; Quay S; Higgins CB
Invest Radiol; 1989 Jul; 24(7):531-6. PubMed ID: 2502502
[TBL] [Abstract][Full Text] [Related]
62. Manganese toxicity upon overexposure.
Crossgrove J; Zheng W
NMR Biomed; 2004 Dec; 17(8):544-53. PubMed ID: 15617053
[TBL] [Abstract][Full Text] [Related]
63. Effect of a peptide derived from fibrinogen degraded by leukocyte elastase on isolated bovine mesenteric arteries.
Saldeen K; Andersson RG
Thromb Res; 1989 Feb; 53(3):279-86. PubMed ID: 2541516
[TBL] [Abstract][Full Text] [Related]
64. The endothelium-dependent relaxation of human middle cerebral artery: effects of activated neutrophils.
Akopov SE; Grigorian MR; Gabrielian ES
Experientia; 1992 Jan; 48(1):34-6. PubMed ID: 1737573
[TBL] [Abstract][Full Text] [Related]
65. [Vascular endothelium and anesthesia].
Hatano Y
Masui; 1994 Oct; 43 Suppl():S186-93. PubMed ID: 7853653
[No Abstract] [Full Text] [Related]
66. Transition metal-chelate complexes as relaxation modifiers in nuclear magnetic resonance.
Brown MA; Johnson GA
Med Phys; 1984; 11(1):67-72. PubMed ID: 6422223
[TBL] [Abstract][Full Text] [Related]
67. Influence of chronic MnCl2 and EDTA treatment on tissue levels and urinary excretion of trace metals in rats.
Scheuhammer AM; Cherian MG
Arch Environ Contam Toxicol; 1982; 11(4):515-20. PubMed ID: 6810768
[No Abstract] [Full Text] [Related]
68. Gastrointestinal AEs seen in the POP trial due to SOD mimetic activity of calmangafodipir?
Karlsson JOG
EBioMedicine; 2019 Sep; 47():27. PubMed ID: 31466917
[No Abstract] [Full Text] [Related]
69. Gastrointestinal AEs seen in the POP trial due to SOD mimetic activity of calmangafodipir? - Authors' reply.
Dear JW
EBioMedicine; 2019 Sep; 47():28. PubMed ID: 31492564
[No Abstract] [Full Text] [Related]
70. Oxidant Stress and Acetaminophen Hepatotoxicity: Mechanism-Based Drug Development.
Ramachandran A; Jaeschke H
Antioxid Redox Signal; 2021 Sep; 35(9):718-733. PubMed ID: 34232786
[No Abstract] [Full Text] [Related]
71. MnDPDP: Contrast Agent for Imaging and Protection of Viable Tissue.
Jynge P; Skjold AM; Falkmer U; Andersson RGG; Seland JG; Bruvold M; Blomlie V; Eidsaunet W; Karlsson JOG
Contrast Media Mol Imaging; 2020; 2020():3262835. PubMed ID: 32994754
[TBL] [Abstract][Full Text] [Related]
72. Calmangafodipir Reduces Sensory Alterations and Prevents Intraepidermal Nerve Fibers Loss in a Mouse Model of Oxaliplatin Induced Peripheral Neurotoxicity.
Canta A; Chiorazzi A; Pozzi E; Fumagalli G; Monza L; Meregalli C; Carozzi VA; Rodriguez-Menendez V; Oggioni N; Näsström J; Marmiroli P; Cavaletti G
Antioxidants (Basel); 2020 Jul; 9(7):. PubMed ID: 32645985
[TBL] [Abstract][Full Text] [Related]
73. Evidence that fodipir (DPDP) binds neurotoxic Pt
Stehr JE; Lundström I; Karlsson JOG
Sci Rep; 2019 Nov; 9(1):15813. PubMed ID: 31676855
[TBL] [Abstract][Full Text] [Related]
74. ROS Modulator Molecules with Therapeutic Potential in Cancers Treatments.
Nicco C; Batteux F
Molecules; 2017 Dec; 23(1):. PubMed ID: 29301225
[TBL] [Abstract][Full Text] [Related]
75. Mangafodipir a Selective Cytoprotectant - with Special Reference to Oxaliplatin and Its Association to Chemotherapy-Induced Peripheral Neuropathy (CIPN).
Karlsson JOG; Andersson RG; Jynge P
Transl Oncol; 2017 Aug; 10(4):641-649. PubMed ID: 28668762
[TBL] [Abstract][Full Text] [Related]
76. Superior therapeutic index of calmangafodipir in comparison to mangafodipir as a chemotherapy adjunct.
Karlsson JO; Kurz T; Flechsig S; Näsström J; Andersson RG
Transl Oncol; 2012 Dec; 5(6):492-502. PubMed ID: 23323161
[TBL] [Abstract][Full Text] [Related]
77. Pretreatment with mangafodipir improves liver graft tolerance to ischemia/reperfusion injury in rat.
Ben Mosbah I; Mouchel Y; Pajaud J; Ribault C; Lucas C; Laurent A; Boudjema K; Morel F; Corlu A; Compagnon P
PLoS One; 2012; 7(11):e50235. PubMed ID: 23226251
[TBL] [Abstract][Full Text] [Related]
78. Effects of MnDPDP and ICRF-187 on Doxorubicin-Induced Cardiotoxicity and Anticancer Activity.
Kurz T; Grant D; Andersson RG; Towart R; De Cesare M; Karlsson JO
Transl Oncol; 2012 Aug; 5(4):252-9. PubMed ID: 22937177
[TBL] [Abstract][Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
